neurocrine biosciences News
Most Popular neurocrine biosciences Story
Insomnia market attracts drug developers
The market for insomnia drugs in the U.S. is growing at a whopping 29 percent per year, hitting $4.6 billion in 2006 and attracting the attention of a wide range of drug developers. More than a Read more...
Latest Headlines
- September 15, 2010
- May 6, 2009
- October 8, 2007
- November 3, 2006
- November 2, 2006
- September 19, 2006
- September 4, 2006
- August 7, 2006
- July 20, 2006
- May 15, 2006
- March 7, 2006
- November 1, 2005
- June 28, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
